News By Tag
News By Location
Follow on Google News
Interventional Cardiology Devices Market Analysis by Top Key Players - Medtronic, Boston Scientific
The Global Interventional Cardiology Devices Market valued at US$ 6.7 billion in 2021 is set to witness a growth rate of ~2 to 3% in the next 5 years.
The rising geriatric population & corresponding rise in the prevalence of coronary artery diseases, rising occurrence of diabetes & concomitant increased risk of coronary heart disease, technical developments in interventional cardiology devices, and favorable reimbursements for interventional cardiology procedures are some of the key factors driving the global interventional cardiology devices market.
APAC to Witness Highest Growth in the Next Five Years
An increasing occurrence of cardiovascular diseases & hypertension, a higher degree of unmet clinical needs, and rising affluence are creating ample opportunities for the interventional cardiology devices market in the APAC region. The development of the interventional cardiology devices market in the APAC is likely to be driven by China and India. Considering the lucrative prospects of the interventional cardiology devices market in the APAC region, prominent companies have expanded their footprint in the region.
Explore Premium Report on Interventional Cardiology Devices Market @ https://meditechinsights.com/
Competitive Landscape Analysis of Interventional Cardiology Devices Market
The interventional cardiology devices market is marked by the presence of players such as Medtronic, Boston Scientific, Abbott, Medinol, Biotronik, SMT, Terumo, Lepu Medical, Microport, among others.
+ 32 498 86 80 79